INST DU CERVEAU ET DE LA MOELLE EPINIERE ICM has a total of 16 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, measurement and pharmaceuticals are CONSORCIO CENTRO DE INVESTIG BIOMEDICA EN RED M P, WILDT LUDWIG and SCIENT NANOMEDICINE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | France | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Biotechnology | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Pouget Pierre | 9 |
#2 | Daye Pierre | 5 |
#3 | Lorenceau Jean | 4 |
#4 | Santin Mathieu | 3 |
#5 | Génin Alexis | 2 |
#6 | Mochel Fanny | 1 |
#7 | Darios Frédéric | 1 |
#8 | Boutry Maxime | 1 |
#9 | Michel Patrick Pierre | 1 |
#10 | Lamari Foudil | 1 |
Publication | Filing date | Title |
---|---|---|
US2021072334A1 | Optimised generation of mri images by a multi-antenna mri system | |
EP3599986A1 | Determination of chromatic isoluminance information for controlling a computer process in a personalised manner | |
FR3064462A1 | BIOMARKER OF COLOR PERCEPTION IN A MAMMAL SUBJECT BASED ON THE FREQUENTIAL MARKING OF THE PUPIL | |
EP3323415A1 | Treatment of neurodegenerative diseases | |
EP3318277A1 | Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases | |
EP2690440A1 | Protein level of C9ORF72 for diagnosing a neurodegenerative disease | |
EP2586875A1 | Non-invasive method for diagnosing and monitoring glioma |